| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 09/28/2005 | CN1675208A Novel fused imidazole derivative |
| 09/28/2005 | CN1675206A Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/28/2005 | CN1675205A Novel quinuclidine derivatives and their use |
| 09/28/2005 | CN1675197A 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/28/2005 | CN1675196A Indole derivatives or benzimidazole derivatives for modulating IKB kinase |
| 09/28/2005 | CN1675185A Therapeutic molecules and methods-1 |
| 09/28/2005 | CN1675184A Caspase inhibitors and uses thereof |
| 09/28/2005 | CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity |
| 09/28/2005 | CN1675180A Indole, indazole, and benzazole derivative |
| 09/28/2005 | CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 09/28/2005 | CN1674942A Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation |
| 09/28/2005 | CN1674931A T cell receptor CDR3 sequences and methods for detection |
| 09/28/2005 | CN1674930A Enzyme containing composition, process of producing said composition and its use |
| 09/28/2005 | CN1674927A Growth hormone releasing peptides |
| 09/28/2005 | CN1674921A Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 09/28/2005 | CN1674898A 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives and related compounds as gyrase and/or topoisomerase IV inhibitors for the treatment of bacterial infections |
| 09/28/2005 | CN1674897A Phenylalkanoic acid and phenyloxyalkanoic acid derivatives as HPPAR activators |
| 09/28/2005 | CN1674886A 软胶囊制剂 Soft capsule preparation |
| 09/28/2005 | CN1674885A Methods for treatment and prevention of gastrointestinal conditions |
| 09/28/2005 | CN1674879A Immunomodulation and effect on cell processes relating to serotonin family receptors and the blood-brain barrier |
| 09/28/2005 | CN1674875A Anti-microbial compositions and methods of using same |
| 09/28/2005 | CN1674795A Method and composition for treating or preventing catabolism or stimulating anabolism in a mammal undergoing metabolic stress |
| 09/28/2005 | CN1673210A Optical isomer of phencynonate and its use in preparing medicine |
| 09/28/2005 | CN1673209A Active metabolic product of phencynonate and its medicinal use |
| 09/28/2005 | CN1672728A Extract of star of bethlehem and its prepn process, medicinal composition and use |
| 09/28/2005 | CN1672726A Life-prolonging Chinese medicine prepn of haw |
| 09/28/2005 | CN1672719A Application of fleece flower root in preparing medicine for treating fatty liver |
| 09/28/2005 | CN1672714A Gastrointestinal decoction |
| 09/28/2005 | CN1672702A Compound liver-nourishing ant tablet and bolus |
| 09/28/2005 | CN1672684A New action and application of methylene blue in preventing dental caries |
| 09/28/2005 | CN1220697C Pyloric spirobacterium inhibitor |
| 09/28/2005 | CN1220683C Acyl derivatives for treating VLA-4 related disorders |
| 09/28/2005 | CN1220517C Medication for curing disease of stomach intestine |
| 09/28/2005 | CN1220512C Capsule with pilose deerhorn blood and gingeng and its preparation method |
| 09/28/2005 | CN1220508C Medicine for curing diseases of digestive system and its preparation method |
| 09/28/2005 | CN1220507C Compound preparation for treating child diarrhea and its preparation method |
| 09/28/2005 | CN1220506C Chinese medicine preparation for treating fatty liver and its preparation method |
| 09/28/2005 | CN1220503C Medicine for treating hepatitis B |
| 09/28/2005 | CN1220502C Medicine with enteron-cleaning effect and its prepn |
| 09/28/2005 | CN1220499C Kidney-invigorating and Yang-strengthening wine |
| 09/28/2005 | CN1220497C Antivirus antioxidizing active extract of proplis and its molecular clathrate compound preparation |
| 09/28/2005 | CN1220496C Bougie for treating virus hepatitis and preparing method thereof |
| 09/28/2005 | CN1220479C Zinc containing dentifrice of reduced astrigency |
| 09/28/2005 | CN1220451C 健康食品 Healthy Food |
| 09/27/2005 | US6949586 Synergistic composition of trans-tetracos-15-enoic acid and Apocynin and method of treatment for hepatotoxicity |
| 09/27/2005 | US6949585 Cytokine antagonist; immunology, viricides, antitumor agents, anticancer agents |
| 09/27/2005 | US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders |
| 09/27/2005 | US6949574 (Oxime)carbamoyl fatty acid amide hydrolase inhibitors |
| 09/27/2005 | US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof. |
| 09/27/2005 | US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 09/27/2005 | US6949544 Inhibitors of c-Jun N-terminal kinases (JNK) and other protein kinases |
| 09/27/2005 | US6949515 Amino acid side chain-modified substrates of the enzyme; obtaining locally limited inhibition; treating inflammation, psoriasis, periodontitis, allergies, arthritis, tumors or autoimmune diseases |
| 09/27/2005 | CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines |
| 09/22/2005 | WO2005087775A1 Tricyclic heterocyclic compound and medicinal composition containing the compound as active ingredient |
| 09/22/2005 | WO2005087729A1 5-hydroxyindole-3-carboxylates derivatives and their use |
| 09/22/2005 | WO2005087240A1 Antidiarrheal agent for livestock and poultry |
| 09/22/2005 | WO2005087230A1 Solid pharmaceutical preparation containing sparingly water-soluble drug |
| 09/22/2005 | WO2005087205A1 Process for producing medicine |
| 09/22/2005 | WO2003099270A8 Methods of treating allergic reactions |
| 09/22/2005 | WO2000075279A3 Nucleotide sequences for gene regulation and methods of use thereof |
| 09/22/2005 | US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases |
| 09/22/2005 | US20050209329 Potentiation of therapeutic effects of fatty acids |
| 09/22/2005 | US20050209316 Lactone formulations and method of use |
| 09/22/2005 | US20050209286 RXR activating molecules |
| 09/22/2005 | US20050209272 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 09/22/2005 | US20050209270 Use of 5HT3 agonists for relaxing the fundus |
| 09/22/2005 | US20050209267 Thioether substituted imidazoquinolines |
| 09/22/2005 | US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol |
| 09/22/2005 | US20050209252 Using an indazole compound |
| 09/22/2005 | US20050209244 N{5-[4-(4-methyl-piperazino-methyl)-benzoylamido]-2-methylphenyl}-4-(3-pyridyl)-2-pyrimidine-amine coated stents |
| 09/22/2005 | US20050209240 such as 4-methoxybenzaldehyde O-{2-[3-(3-ethoxy-4-methoxyphenyl)-5,6-dihydro-4H-pyridazin-1-yl]-2-oxoethyl}oxime; phosphodiesterase IV inhibitors |
| 09/22/2005 | US20050209230 2,4-Pyrimidinediamine compounds and their uses |
| 09/22/2005 | US20050209216 Inhibit the synthesis of TNF-alpha (TNF=tumor necrosis factor); use treating diseases linked to immune and inflammatory disorders or as analgesics; e.g. 7-(2-(4-(3-Trifluoromethylphenyl)piperazin-1-yl)ethyl)quinoline |
| 09/22/2005 | US20050209214 1-oxa-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/22/2005 | US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof |
| 09/22/2005 | US20050209161 Drugs for treatment of inflammation/blood brain barrier degradation;administering to a subject in need of such treatment, a pharmaceutically effective amount of a peptide antagonist of zonulin, wherein the peptide antagonist binds to a zonula occludens toxin receptor |
| 09/22/2005 | US20050209159 Effectors of dipeptidyl peptidase IV for topical use |
| 09/22/2005 | US20050208653 Pancreatic progenitor cell culture for use in prevention and treatment of infection, diabetes and liver disorders |
| 09/22/2005 | US20050208525 Nucleotide sequences coding preferential polypeptide for use in the treatment defects in immune and inflammatory response |
| 09/22/2005 | US20050208494 Novel proteins and dnas thereof |
| 09/22/2005 | US20050208197 Agonists/antagonists of muscarine M3 receptors, obtained from beer through isolation and purification; distillation; chromatography; side effect reduction |
| 09/22/2005 | US20050208137 comprising angiogenesis inhibitor retinoic acid, taxol and polymeric carrier polylactone; treating cancer, angiogenic-dependent diseases, embolizing blood vessels, and eliminating biliary, urethral, esophageal, tracheal/bronchial obstructions, corneal neovascularization; coated stents with the mixture |
| 09/22/2005 | US20050208131 Mixing active ingredients and at least one excipient to obtain powdered mixture, compacting, breaking and sieving product to chosen mesh size to obtain similar sized granules, forming granules into unitary dosage forms; alleviates active ingredient losses during manufacture; ensures content uniformity |
| 09/22/2005 | US20050208129 Prolonged release bioadhesive therapeutic systems |
| 09/22/2005 | US20050208124 Drugs containing riboflavin-type compounds |
| 09/22/2005 | US20050208064 Peptide capable of inducing immune response to human gastric cancer and agent for preventing or treating human gastric cancer, containing the peptide |
| 09/22/2005 | US20050208042 Inducing lack of responsiveness to an antigen in an individual having a transplanted organ, tissue, cell; administering an effective amount of a humanized antibody; one antigen binding region of nonhuman origin and a portion of an immunoglobulin heavy chain of human origin |
| 09/22/2005 | US20050208035 Nutritional composition for treating an immune condition |
| 09/22/2005 | CA2560079A1 Process for producing medicine |
| 09/22/2005 | CA2559813A1 Antidiarrheal agent for livestock and poultry |
| 09/22/2005 | CA2558219A1 Poorly water-soluble drug-containing solid formulation |
| 09/22/2005 | CA2555908A1 Use of corticotroph-derived glycoprotein hormone to treat liver steatosis |
| 09/21/2005 | EP1577387A1 Preventives/remedies for cancer |
| 09/21/2005 | EP1577323A1 Metastin derivative and use thereof |
| 09/21/2005 | EP1577315A1 Process for producing hop glume polyphenol |
| 09/21/2005 | EP1577299A1 Alkynyl-substituted azasugar derivative and drug containing the same as the active ingredient |
| 09/21/2005 | EP1576964A1 Protease inhibitor |
| 09/21/2005 | EP1576961A1 Pharmaceutical compound containing silymarin and carbopol, production method thereof and use of same as a regenerator of tissue and pancreatic cells with endogenous secretion damaged by diabetes mellitus |
| 09/21/2005 | EP1576954A1 Preferential inhibition of release of pro-inflammatory cytokines |
| 09/21/2005 | EP1576168A2 Therapeutic polypeptides nucleic acids encoding same and methods of use |